✦ LIBER ✦

Pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers treated with trimethoprim–sulphamethoxazole

✍ Scribed by L. Shiveley; C. Struthers-Semple; S. Cox; J. Sawyer

Book ID: 108849103
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 173 KB
Volume: 33
Category: Article
ISSN: 0269-4727
DOI: 10.1111/j.1365-2710.2008.00889.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of Single Oral Doses of

Pharmacokinetics of Single Oral Doses of Apricitabine, a Novel Deoxycytidine Analogue Reverse Transcriptase Inhibitor, in Healthy Volunteers

✍ Tom Holdich, LeeAnn Shiveley, Dr James Sawyer 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 115 KB

Multiple-Dose Pharmacokinetics of Aprici

Multiple-Dose Pharmacokinetics of Apricitabine, a Novel Nucleoside Reverse Transcriptase Inhibitor, in Patients with HIV-1 Infection

✍ Pedro Cahn, Maria Rolon, Isabel Cassetti, LeeAnn Shiveley, Tom Holdich, James Sa 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 124 KB

Evaluation of steady-state pharmacokinet

Evaluation of steady-state pharmacokinetic interactions between ritonavir-boosted BILR 355, a non-nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjects

✍ F. Huang; L. Allen; D. B. Huang; F. Moy; R. Vinisko; T. Nguyen; L. Rowland; T. R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 638 KB

Pre-clinical pharmacokinetics of UK-453,

Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man

✍ Allan, G.; Davis, J.; Dickins, M.; Gardner, I.; Jenkins, T.; Jones, H.; Webster, 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 252 KB

Pharmacokinetics and safety assessments

Pharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers

✍ Timothy G. K. Mant; Daniel Bradford; Dipti M. Amin; Jaya Pisupati; Yoshikazu Kam 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

Single-Dose Pharmacokinetics and Pharmac

Single-Dose Pharmacokinetics and Pharmacodynamics of Sergliflozin Etabonate, a Novel Inhibitor of Glucose Reabsorption, in Healthy Volunteers and Patients With Type 2 Diabetes Mellitus

✍ Hussey, Elizabeth K.; Clark, Richard V.; Amin, Dipti M.; Kipnes, Mark S.; O'Conn 📂 Article 📅 2010 🏛 Sage Publications 🌐 English ⚖ 312 KB